Hiroki Ueo

815 total citations
28 papers, 501 citations indexed

About

Hiroki Ueo is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Hiroki Ueo has authored 28 papers receiving a total of 501 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 15 papers in Molecular Biology and 12 papers in Cancer Research. Recurrent topics in Hiroki Ueo's work include Cancer Cells and Metastasis (6 papers), MicroRNA in disease regulation (5 papers) and Breast Cancer Treatment Studies (5 papers). Hiroki Ueo is often cited by papers focused on Cancer Cells and Metastasis (6 papers), MicroRNA in disease regulation (5 papers) and Breast Cancer Treatment Studies (5 papers). Hiroki Ueo collaborates with scholars based in Japan, Switzerland and China. Hiroki Ueo's co-authors include Koshi Mimori, Masaki Mori, K Sugimachi, Hidetoshi Eguchi, Ryutaro Uchi, Sayuri Akiyoshi, Tomoya Sudo, Tae Matsumura, Junji Kurashige and Yuki Takano and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Hiroki Ueo

27 papers receiving 496 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroki Ueo Japan 13 348 206 173 57 46 28 501
Deepika Neelakantan United States 9 298 0.9× 180 0.9× 186 1.1× 56 1.0× 34 0.7× 11 463
Zejun Fang China 15 381 1.1× 196 1.0× 169 1.0× 77 1.4× 51 1.1× 27 548
M. Ángeles Villaronga Spain 17 420 1.2× 162 0.8× 139 0.8× 74 1.3× 41 0.9× 28 577
Xun‐Xun Wan China 9 331 1.0× 165 0.8× 149 0.9× 50 0.9× 39 0.8× 9 458
Mingxin Wen China 10 520 1.5× 229 1.1× 167 1.0× 47 0.8× 47 1.0× 17 615
Mengxian Zhang China 8 355 1.0× 135 0.7× 172 1.0× 46 0.8× 48 1.0× 16 528
Qiu-Wan Wu China 11 308 0.9× 206 1.0× 143 0.8× 43 0.8× 49 1.1× 14 460
Raquel Batlle Spain 7 345 1.0× 190 0.9× 227 1.3× 56 1.0× 87 1.9× 7 552
Alan Ka‐Lun Kai Hong Kong 6 361 1.0× 310 1.5× 125 0.7× 52 0.9× 42 0.9× 6 513
Tamer Yağcı Türkiye 13 357 1.0× 162 0.8× 274 1.6× 53 0.9× 38 0.8× 32 550

Countries citing papers authored by Hiroki Ueo

Since Specialization
Citations

This map shows the geographic impact of Hiroki Ueo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroki Ueo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroki Ueo more than expected).

Fields of papers citing papers by Hiroki Ueo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroki Ueo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroki Ueo. The network helps show where Hiroki Ueo may publish in the future.

Co-authorship network of co-authors of Hiroki Ueo

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroki Ueo. A scholar is included among the top collaborators of Hiroki Ueo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroki Ueo. Hiroki Ueo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ijichi, Hideki, et al.. (2024). Breast mucoepidermoid carcinoma with a rare CRTC3–MAML2 fusion. International Cancer Conference Journal. 13(4). 481–487. 3 indexed citations
2.
Ueo, Hiroki, Itsushi Minoura, Hiroaki Ueo, et al.. (2022). Development of an intraoperative breast cancer margin assessment method using quantitative fluorescence measurements. Scientific Reports. 12(1). 8520–8520. 1 indexed citations
3.
Masuda, Takaaki, Hiroki Ueo, Yuichiro Kai, et al.. (2020). N-Cadherin mRNA Levels in Peripheral Blood Could Be a Potential Indicator of New Metastases in Breast Cancer: A Pilot Study. International Journal of Molecular Sciences. 21(2). 511–511. 9 indexed citations
4.
Okamoto, Masahiro, Hiroki Ueo, Hideki Ijichi, et al.. (2020). Efficacy of Adjuvant Combination Therapy With Trastuzumab and Chemotherapy in HER2-positive Early Breast Cancer: A Single Institutional Cohort Study from Clinical Practice. Anticancer Research. 40(6). 3315–3323. 5 indexed citations
5.
6.
Ijichi, Hideki, Katsumi Takizawa, Hiroki Ueo, et al.. (2020). The clinical usefulness of the CTS5 in the prediction of late distant recurrence in postmenopausal women with estrogen receptor-positive early breast cancer. Breast Cancer. 28(1). 67–74. 6 indexed citations
7.
Masuda, Takaaki, Yoshiaki Shinden, Hiroki Ueo, et al.. (2018). Circulating Pre-microRNA-488 in Peripheral Blood Is a Potential Biomarker for Predicting Recurrence in Breast Cancer. Anticancer Research. 38(8). 4515–4523. 27 indexed citations
8.
Inoue, Yuka, Nami Yamashita, Hiroki Ueo, et al.. (2018). The Clinical Usefulness of the LigaSure™ Small Jaw in Axillary Lymph Node Dissection in Patients with Breast Cancer. Anticancer Research. 38(4). 2359–2362. 6 indexed citations
9.
Shinden, Yoshiaki, Tomohiro Iguchi, Sayuri Akiyoshi, et al.. (2015). miR-29b is an indicator of prognosis in breast cancer patients. Molecular and Clinical Oncology. 3(4). 919–923. 38 indexed citations
10.
Shinden, Yoshiaki, Sayuri Akiyoshi, Hiroki Ueo, et al.. (2015). Diminished expression of MiR-15a is an independent prognostic marker for breast cancer cases.. PubMed. 35(1). 123–7. 27 indexed citations
11.
Sawada, Genta, Yusuke Takahashi, Atsushi Niida, et al.. (2014). Loss of CDCP1 Expression Promotes Invasiveness and Poor Prognosis in Esophageal Squamous Cell Carcinoma. Annals of Surgical Oncology. 21(S4). 640–647. 14 indexed citations
12.
Matsumura, Tae, K Sugimachi, Yusuke Takahashi, et al.. (2014). Clinical Significance of GAB2, a Scaffolding/Docking Protein Acting Downstream of EGFR in Human Colorectal Cancer. Annals of Surgical Oncology. 21(S4). 743–749. 17 indexed citations
13.
Sakimura, Shotaro, Junji Kurashige, K Sugimachi, et al.. (2014). Abstract 1478: Decreased expression of miR-506 induced epithelial-mesenchymal transition and poor prognosis in gastric cancer patients. Cancer Research. 74(19_Supplement). 1478–1478. 1 indexed citations
14.
Sawada, Genta, Hiroki Ueo, Tae Matsumura, et al.. (2013). CHD8 is an independent prognostic indicator that regulates Wnt/β-catenin signaling and the cell cycle in gastric cancer. Oncology Reports. 30(3). 1137–1142. 35 indexed citations
15.
Sawada, Genta, Hiroki Ueo, Tae Matsumura, et al.. (2013). Loss of COP1 expression determines poor prognosis in patients with gastric cancer. Oncology Reports. 30(4). 1971–1975. 18 indexed citations
16.
Takahashi, Yusuke, Genta Sawada, Tetsuya Sato, et al.. (2013). Microarray analysis reveals that high mobility group A1 is involved in colorectal cancer metastasis. Oncology Reports. 30(3). 1488–1496. 9 indexed citations
17.
Ishibashi, Masahisa, Ryunosuke Kogo, Kohei Shibata, et al.. (2013). Clinical Significance of PICT1 in Patients of Hepatocellular Carcinoma with Wild-Type TP53. Annals of Surgical Oncology. 20(S3). 537–544. 9 indexed citations
18.
Sugimachi, K, Takehiko Yokobori, Hisae Iinuma, et al.. (2013). Aberrant Expression of Plastin-3 Via Copy Number Gain Induces the Epithelial–Mesenchymal Transition in Circulating Colorectal Cancer Cells. Annals of Surgical Oncology. 21(11). 3680–3690. 35 indexed citations
19.
Mima, Kosuke, Takeo Fukagawa, Junji Kurashige, et al.. (2013). Gene expression of bone morphogenic protein 8B in the primary site, peripheral blood and bone marrow of patients with gastric cancer. Oncology Letters. 6(2). 387–392. 15 indexed citations
20.
Takahashi, Yusuke, Genta Sawada, Junji Kurashige, et al.. (2013). Tumor-derived tenascin-C promotes the epithelial-mesenchymal transition in colorectal cancer cells.. PubMed. 33(5). 1927–34. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Deepika Neelakantan Breakdown of academic impact, for papers by Zejun Fang Breakdown of academic impact, for papers by M. Ángeles Villaronga Breakdown of academic impact, for papers by Xun‐Xun Wan Breakdown of academic impact, for papers by Mingxin Wen Breakdown of academic impact, for papers by Mengxian Zhang Breakdown of academic impact, for papers by Qiu-Wan Wu Breakdown of academic impact, for papers by Raquel Batlle Breakdown of academic impact, for papers by Alan Ka‐Lun Kai Breakdown of academic impact, for papers by Tamer Yağcı
Rankless by CCL
2026